摘要
临床药师参与1例肺癌合并上腔静脉综合征患者的治疗过程,通过限制补液量,以及选择无需水化的化疗方案进行干预,建议护士采取下肢静脉留置导管输入补液,并对化疗药物配置及化疗期间可能出现的不良反应进行监护,患者在上腔静脉支架置入术及相关治疗之后面部、颈部、右上肢肿胀较前缓解,胸闷气促、咳嗽咳痰逐渐好转,肝肾功能及电解质指标均在正常范围,明确诊断后,排除化疗禁忌,开始治疗。
Clinical pharmacists participated in the treatment of one patient with lung cancer complicated with superior vena cava syndrome. It was suggested that the venous indwelling catheter be taken into the lower limb to fill fluid,the volume of fluid infusion be limited,and the chemotherapy regimen without hydration was chosen. The risks that might occur during the compounding process and chemotherapy period were monitored. After the vena cava stent implantation and some related treatment,the patient felt that the swelling face,neck and right upper extremity relieved,the chest tightness,shortness of breath,cough and expectoration gradually improved,and the function of liver and kidney,and electrolyte indices were all within the normal ranges. After the diagnosis was determined and chemotherapy contraindications were eliminated,chemotherapy started.
作者
左成淳
金知萍
Zuo Chengchun;Jin Zhiping(Department of Pharmacy, Zhongshan Hospital Affiliated with Fudan Univesity, Shanghai 200032, Chin)
出处
《中国药师》
CAS
2018年第7期1240-1242,共3页
China Pharmacist
关键词
肺癌
上腔静脉综合征
药学服务
Lung cancer
Superior vena eava syndrome
Pharmaceutical care